Schedule 13G ownership disclosure

UNITED THERAPEUTICS CORP DEL COM

Security class unavailable · CUSIP: 91307C102

Event date: 2023-06-30

Legacy cover-page extraction is best effort and may not include every reporting person.

Filing-level shares
4,688,824
Percent of class
10.0100%

Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.

Source: SEC EDGAR filing

Filing metadata

Accession number
0000902219-23-000033
Form type
SC 13G/A
Filer
UNITED THERAPEUTICS Corp
CIK
CIK 1082554
Filed
Jul 10, 2023
Reporting period
Jun 30, 2023
Description
Schedule 13G beneficial ownership

Explore SEC Filings Hub